The patent-pending methodology and surface chemistry used in the manufacture of Sona's Gemini and Omni gold nanorods makes them perfectly suited for both in-vitro and in-vivo applications.
Point of Care Diagnostics
Lateral Flow Assays.
Detect more than one biomarker.
Distinct visual difference between test lines.
Scalable and cost effective.
Used as a carrier device to deliver payload(s) of drug molecules to cells, tissue, or organs.
High efficiency of the GNRs for delivering pain relieving agents over other nanoparticles.
Eliminates the genetic modification of target cells.
Nanorods absorb in the near IR, and generate heat when excited with IR light.
Nanorods can be conjugated with tumor targeting motifs and ingested. When a patient is exposed to IR light nanorods are locally heated, destroying only the cancerous tissue while leaving healthy cells intact.
Gold bio-markers with plasmonic resonance have many advantages.
Produce high image quality.
Yield both qualitative and quantitative data.
More intuitive for the health care practitioners to interpret.
Our advancements in gold nanotechnology have the potential to transform the diagnostic and medical treatment markets.